Jan 30 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL COMPLETES OVERSUBSCRIBED FINANCING TO ADVANCE ITS CANCER IMMUNOTHERAPY RESEARCH AND DEVELOPMENT
Jan 30 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL COMPLETES OVERSUBSCRIBED FINANCING TO ADVANCE ITS CANCER IMMUNOTHERAPY RESEARCH AND DEVELOPMENT